TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT02358187: A Vaccine Trial for Low Grade Gliomas

Sponsor: James Felker · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 25 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$2,028,600

Rescue Site Savings

+$1,352,400

Unlock Full NCT02358187 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT02358187 Rescue Dossier →